Procter & Gamble [PGHL] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison

Procter & Gamble Health Ltd.

NSE
Loading...

Sun Pharma Advanced Research Company Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Procter & Gamble Health Ltd. wins in 16 metrics, Sun Pharma Advanced Research Company Ltd. wins in 2 metrics, with 0 ties. Procter & Gamble Health Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Procter & Gamble Health Ltd. Sun Pharma Advanced Research Company Ltd. Better
P/E Ratio (TTM) 36.48 -13.65 Procter & Gamble Health Ltd.
Price-to-Book Ratio 13.94 -13.55 Procter & Gamble Health Ltd.
Debt-to-Equity Ratio 1.00 -1.21 Procter & Gamble Health Ltd.
PEG Ratio -2.49 -11.15 Procter & Gamble Health Ltd.
EV/EBITDA 21.21 -22.27 Procter & Gamble Health Ltd.
Profit Margin (TTM) 21.76% -53.22% Procter & Gamble Health Ltd.
Operating Margin (TTM) 27.97% -700.71% Procter & Gamble Health Ltd.
EBITDA Margin (TTM) 27.97% N/A N/A
Return on Equity 37.34% 157.88% Sun Pharma Advanced Research Company Ltd.
Return on Assets (TTM) 25.30% -102.08% Procter & Gamble Health Ltd.
Free Cash Flow (TTM) $2.07B $-3.71B Procter & Gamble Health Ltd.
Dividend Yield 5.20% N/A N/A
1-Year Return 7.82% 34.88% Sun Pharma Advanced Research Company Ltd.
Price-to-Sales Ratio (TTM) 6.41 87.98 Procter & Gamble Health Ltd.
Enterprise Value $83.62B $50.87B Procter & Gamble Health Ltd.
EV/Revenue Ratio 6.20 95.73 Procter & Gamble Health Ltd.
Gross Profit Margin (TTM) 70.63% -59.53% Procter & Gamble Health Ltd.
Revenue per Share (TTM) $812 $2 Procter & Gamble Health Ltd.
Earnings per Share (Diluted) $142.69 $-8.25 Procter & Gamble Health Ltd.
Beta (Stock Volatility) 0.09 0.19 Procter & Gamble Health Ltd.

Procter & Gamble Health Ltd. vs Sun Pharma Advanced Research Company Ltd. Stock Performance Analysis

Loading Price Chart...

PGHL
SPARC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Procter & Gamble Health Ltd.-0.96%0.44%17.48%27.00%9.90%8.81%
Sun Pharma Advanced Research Company Ltd.2.36%12.49%39.95%100.62%67.89%69.61%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Procter & Gamble Health Ltd.7.82%23.28%7.21%805.06%944.18%1,263.48%
Sun Pharma Advanced Research Company Ltd.34.88%14.54%-3.55%-20.47%148.26%-23.02%

Performance & Financial Health Analysis: Procter & Gamble Health Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricPGHLSPARC
Market Information
Market Cap i₹86.41B₹46.75B
Market Cap CategoryMid capSmall cap
10 Day Avg. Volume i29,9372,401,062
90 Day Avg. Volume i19,0442,083,443
Last Close₹6,226.50₹229.03
52 Week Range₹4,707.00 - ₹6,739.00₹108.00 - ₹248.75
% from 52W High-7.60%-7.93%
All-Time High₹7,500.00 (Feb 08, 2021)₹875.00 (Apr 24, 2006)
% from All-Time High-16.98%-73.83%
Growth Metrics
Quarterly Revenue Growth0.21%-0.43%
Quarterly Earnings Growth-0.15%-0.43%
Financial Health
Profit Margin (TTM) i0.22%-0.53%
Operating Margin (TTM) i0.28%-7.01%
Return on Equity (TTM) i0.37%1.58%
Debt to Equity (MRQ) i1.00-1.21
Cash & Liquidity
Book Value per Share (MRQ)₹373.35₹-10.63
Cash per Share (MRQ)₹172.39₹0.03
Operating Cash Flow (TTM) i₹3.20B₹-3,484,287,000
Levered Free Cash Flow (TTM) i₹2.01B₹-3,425,094,000
Dividends
Last 12-Month Dividend Yield i5.20%N/A
Last 12-Month Dividend i₹285.00N/A

Valuation & Enterprise Metrics Analysis: Procter & Gamble Health Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricPGHL (Apr 24, 2026)SPARC (Apr 22, 2026)
Price Ratios
P/E Ratio (TTM) i36.48-13.65
Forward P/E i27.462.60
PEG Ratio i-2.49-11.15
Price to Sales (TTM) i6.4187.98
Price to Book (MRQ) i13.94-13.55
Market Capitalization
Market Capitalization i₹86.41B₹46.75B
Enterprise Value i₹83.62B₹50.87B
Enterprise Value Metrics
Enterprise to Revenue i6.2095.73
Enterprise to EBITDA i21.21-22.27
Risk & Other Metrics
Beta i0.090.19
Book Value per Share (MRQ) i₹373.35₹-10.63

Financial Statements Comparison: Procter & Gamble Health Ltd. vs Sun Pharma Advanced Research Company Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricPGHL (2024)SPARC (2025)
Revenue/Sales i11.29B717.66M
Cost of Goods Sold i3.59B1.10B
COGS % of Revenue i31.8%153.2%
Gross Profit i7.70B-381.94M
Gross Margin i68.2%-53.2%
Research & Development i38.60MN/A
Operating Income (EBIT) i2.79B-3.34B
Operating Margin i24.7%-465.5%
EBITDA i3.22B-3.23B
EBITDA Margin i28.5%-450.0%
Pre-Tax Income i2.73B-3.43B
Pre-Tax Income % of Revenue i24.2%-477.6%
Income Tax i723.40M-2.72M
Income Tax % of Revenue i6.4%-0.4%
Net Income (Profit) i2.01B-3.43B
Profit Margin i17.8%-477.3%

Balance Sheet & Liquidity Metrics

MetricPGHL (2024)SPARC (2025)
Cash & Equivalents i2.39B19.64M
Total Current Assets i5.24B261.97M
Total Current Assets % of Revenue i46.4%36.5%
Total Current Liabilities i2.19B3.74B
Total Current Liabilities % of Revenue i19.4%521.5%
Long-Term Debt i68.80M1.07B
Long-Term Debt % of Revenue i0.6%149.0%
Total Shareholders Equity i5.38B-2.17B
Retained Earnings i1.58B-23.22B
Retained Earnings % of Revenue i14.0%-3,235.0%
Property, Plant & Equipment i1.26B178.02M

Cash Flow Statement Comparison

MetricPGHL (2024)SPARC (2025)
Operating Cash Flow i3.20B-3.48B
Operating Cash Flow % of Revenue i28.4%-485.5%
Capital Expenditures i-217.30M-97.45M
Free Cash Flow i2.07B-3.71B
FCF Margin i18.3%-516.4%
Debt Repayment iN/A-3.69B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricPGHLSPARC
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i16.60M324.52M
Float Shares i7.93M91.32M
% Held by Insiders i52.20%72.96%
% Held by Institutions i15.99%2.56%
% Held by Public i31.81%24.48%

Dividend Analysis & Yield Comparison: Procter & Gamble Health Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricPGHLSPARC
Last 12-Month Dividend i₹285.00N/A
Last 12-Month Dividend Yield i5.20%N/A
3-Year Avg Annual Dividend i₹213.33N/A
3-Year Avg Dividend Yield i1.75%N/A
3-Year Total Dividends i₹640.00N/A
Ex-Dividend DateFeb 12, 2026N/A